- Home
- IGR vs TLRY Comparison
IGR vs TLRY Comparison
Compare IGR & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IGR | TLRY |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 693.0M | 570.4M |
| IPO Year | 2003 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IGR | TLRY |
|---|---|---|
| Price | $12.58 | $4.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 465.0K | ★ 3.3M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | ★ 13.93% | N/A |
| EPS Growth | N/A | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.15 | $0.77 |
| 52 Week High | $13.67 | $15.70 |
Technical Indicators
Market Signals| Indicator | IGR | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 87.48 | 35.52 |
| Support Level | $4.50 | $3.67 |
| Resistance Level | N/A | $4.91 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | 0.96 | -0.06 |
| Stochastic Oscillator | 87.55 | 2.96 |
Price Performance
Historical ComparisonAbout IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.